Risks of COVID19 in the Pregnant Population

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
COVID19
Interventions
OTHER

Biospecimen collection

"Maternal blood, vaginal swab, and anorectal swab will be obtained at the time of enrollment prior to delivery. A sample of breastmilk before hospital discharge and again at six weeks postpartum will be obtained if the mother is lactating.~Neonatal specimens collected following delivery will include placental tissue, fetal membrane roll, umbilical cord tissue, umbilical cord blood, and an anorectal swab."

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04379284 - Risks of COVID19 in the Pregnant Population | Biotech Hunter | Biotech Hunter